Comparison of clinical presentation of benign and malignant ovarian tumours.
نویسندگان
چکیده
OBJECTIVE To compare clinical presentation of benign and malignant ovarian tumours and to enlist and identify symptoms that could lead to early diagnosis of ovarian carcinoma METHODS It was a consecutive case series study. All patients who on abdominal or bimanual examination and abdominal U/S were found to have ovarian cyst or tumour, and later underwent laparotomy were included. RESULTS The study included 110 patients, of whom 80 (72%) had benign and the rest malignant disease. Mean age of patients with malignancy was 49.07+/-18.5 years and for benign 36.95+/-8.2 years (p= 0.0001). Eleven patients with benign tumours were asymptomatic, while 66% had abdominal pain. On the other hand 70% patients with ovarian malignancy had abdominal symptoms with abdominal pain in (76%). Abdominal enlargement and abdominal mass were significantly more in malignant tumours (p=0.003, p= 0.005). Gastrointestinal symptoms were present in both groups but more significant in malignant group (p=0.004). Constitutional symptoms like loss of appetite and weight loss were only present in malignant group (p=0.001). Seventy percent of the malignant tumours presented at late stage (III & IV). Histopathology of benign tumours revealed follicular/luteal cyst in 32% cases while serous cyst adenoma in 23%. Histopathology of malignant tumours showed serous cyst carcinoma in 46.7% and mucinous cyst carcinoma in 26% cases. CONCLUSIONS Ovarian malignancy is a silent killer, especially affecting women above 50 years. Although presentation is often vague and non specific, symptoms are definitely present. Therefore a proper bimanual examination and appropriate investigations should be done at the outset in post menopausal women.
منابع مشابه
Evaluation of Clinico Ultra-Sonography and Pathological Findings of Ovarian Masses in Patients referred to Kosar Hospital, Qazvin
Introduction: Today, despite many optimal imaging methods for evaluation of ovarian mass, the survival rate of patient was not significantly changed. Object of present study was evaluation of Clinico Ultra- Sonography and pathological findings of ovarian masses in patients referred to Kosar Hospital. Methods: In this analytic study, information of clinico Ultra-Sonography and pathological findi...
متن کاملClinicohistological pattern of ovarian tumours in Peshawar region.
BACKGROUND Ovarian tumours are one of the major health problems confronting the general practitioners in general and gynaecologists in particular. Ovarian tumours may either be asymptomatic, found on the routine ultrasound examination or symptoms may be vague till the patient has an acute emergency like torsion or rupture of a benign cyst. The worst is late presentation of a malignant ovarian t...
متن کاملEvaluation of the prognostic value of CD117 and CK20 biomarkers in urinary bladder carcinoma
Background: Over-expression of CD117 and cytokeratin 20 (CK20) is seen in many malignancies. Given that few studies have been conducted regarding the role of these biomarkers in the etiology of bladder tumours, this study aimed to evaluate the prognostic value of CD117 and CK 20 biomarkers in the benign and malignant tumours of urinary bladder carcinoma. Methods: This case-control study was co...
متن کاملP-163: Evaluation of Ovarian Masses in Shahid Sadoughi and Mother Hospital during 2008-2012
Background: Ovarian cancer is the fifth most common cancer in woman and the fifth most frequent cause of cancer death. Ovarian cancers are usually asymptomatic until metastasized, patients have advanced disease at diagnosis in more than 2/3 of the cases. Totally 75-80 % of ovarian masses are benign. The strongest patient related risk factor for ovarian cancer is increasing age. The most ovarian...
متن کاملDNA Cytometry and Nuclear Morphometry in Ovarian Benign, Borderline and Malignant Tumors
BACKDROUND Ovarian carcinoma is a leading cause of death in gynecological malignancy. Ovarian surface epithelial serous and mucinous tumours are classified as benign, borderline, and malignant. The identification of borderline tumours most likely to act aggressively remains an important clinical issue. AIM This work aimed to study DNA ploidy and nuclear area in ovarian serous and mucinous; be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- JPMA. The Journal of the Pakistan Medical Association
دوره 59 1 شماره
صفحات -
تاریخ انتشار 2009